Marketing-authorisation holder · Spain

Dose Innova S.L.

Spain3 medicines2 countries

3 medicines in 2 countries, as authorisation holder and manufacturer.

Medicines

Every medicine in the registers under its name, current ones first.

3 medicines

Medicine	Substance	Country	Status	Authorised
DELAXIN 30 mg delayed-release capsule	Duloxetine	Saudi Arabia	Authorised
DELAXIN 60 mg delayed-release capsule	Duloxetine	Saudi Arabia	Authorised
VASOCONSTRICTOR PENSA0,05 g · Solucion para pulverizacion nasal	Naphazoline	Spain	Withdrawn	1954

Countries

Where it holds or makes medicines, with how many are current.

Country	Medicines	Current	Past	Companies
Saudi Arabia	2	2	0	Companies All medicines
Spain	1	0	1	Companies All medicines

Know your medicines, with the sources.

One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.

Join Prognia free

Marketing-authorisation holder · Spain

Dose Innova S.L.

Spain3 medicines2 countries

3 medicines in 2 countries, as authorisation holder and manufacturer.

Its medicines

Medicines

Every medicine in the registers under its name, current ones first.

3 medicines

Medicine	Substance	Country	Status	Authorised
DELAXIN 30 mg delayed-release capsule	Duloxetine	Saudi Arabia	Authorised
DELAXIN 60 mg delayed-release capsule	Duloxetine	Saudi Arabia	Authorised
VASOCONSTRICTOR PENSA0,05 g · Solucion para pulverizacion nasal	Naphazoline	Spain	Withdrawn	1954

Countries

Where it holds or makes medicines, with how many are current.

Country	Medicines	Current	Past	Companies
Saudi Arabia	2	2	0	Companies All medicines
Spain	1	0	1	Companies All medicines

Know your medicines, with the sources.

One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.

Join Prognia free

Top substances

The active substances in most of its medicines.

Names in the registers

How the registers spell it, normalised: legal forms, accents and capitals removed.

dose innova
dose innova s l

Sources and licences

Compiled by Prognia from the public medicine and company registers below. Logos are not used.

Agencia Española de Medicamentos y Productos Sanitarios (CIMA)

Fuente de la información: AEMPS (CIMA).

Licence: AEMPS open data reuse with attribution

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required

Saudi Food and Drug Authority

Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.

Licence: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only

Report an error or request removalCorrections from the company itself are welcome.

At a glance

Type: Marketing-authorisation holder
Headquarters: Spain
Medicines: 3
Countries: 2
Roles: Authorisation holder and manufacturer

Spain: more companies

Ranked by their number of medicines.

Show all